Click the play button below for an interview with David DeCuir at InformexCompany ProfileAlbemarle Fine Chemistry Services business unit serves as a single-source provider for life science customers interested in taking a product from R&D to commercial production. The company's flexible manufacturing facilities (South Haven MI for cGMP operations and Tyrone PA for non-cGMP operations) set the industry standard for manufacturing milligram to multi-ton quantities. Other sites within Albemarle also have unique capabilities and are available for custom manufacturing if the opportunity requires them. The FCS R&D group consists of over 75 chemists and engineers backed up by Albemarle's 300 other technical professionals. Key personnel at all facilities take a team approach to their projects, working directly with the customer every step of the way. Multi-disciplined teams combine the expert chemistry, engineering, process development, safety and health expertise needed to ensure every project's success. Albemarle also supplies fine and specialty chemicals to many of the leading producers of consumer products throughout the world. Complex, multi-step processes are Albemarle's core competence, and our analytical capabilities are state-of-the-art. Our products rely on technologies as different from one another as alkylation, organometallic chemistry, halogenation, amination and carbonylation. Every Albemarle product relies on challenging chemistry or complex and difficult manufacturing processes. Albemarle, headquartered in Baton Rouge, Louisiana, is a leading global producer of specialty chemicals for refinery catalysts, consumer electronics, pharmaceuticals, agricultural, automotive and industrial products; and construction and packaging materials. The Company's three business segments, Polymer Chemicals, Catalysts and Fine Chemicals - which includes custom manufacturing services for the life sciences market - serves customers in more than 80 countries, generating revenue of approximately $2.5 billion. Albemarle today has approximately 4,000 employees and has developed industry-leading positions in a number of end markets, including bromine and mineral-based flame retardants, aluminum alkyl catalysts and metallocene co-catalysts for polyolefins, bromine and bulk ibuprofen, refinery catalysts and custom manufacturing. Learn more about the Company at www.albemarle.com.